Hyperglycemia Is the Main Mediator of Prediabetes- and Type 2 Diabetes-Associated Impairment of Microvascular Function: The Maastricht Study.
Sörensen BM, Houben AJHM, Berendschot TTJM, Schouten JSAG, Kroon AA, van der Kallen CJH, Henry RMA, Koster A, Reesink KD, Dagnelie PC, Schaper NC, Schalkwijk CG, Schram MT, Stehouwer CDA.
http://care.diabetesjournals.org/content/early/2017/06/14/dc17-0574